Brief: Sedana Medical Q2 EBITDA Loss Widens To Sek 2.3 Million
Aug 22 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* Q2 NET SALES SEK 17.4 MILLION VERSUS SEK 14.5 MILLION YEAR
AGO
* Q2 EBITDA LOSS SEK 2.3 MILLION VERSUS LOSS SEK 1.0 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr4dsVjR
Further company coverage: SEDANA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln